Oxford Immunotec Global (NASDAQ:OXFD) Stock Price Crosses Below Fifty Day Moving Average of $16.17
Oxford Immunotec Global PLC (NASDAQ:OXFD) passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $16.17 and traded as low as $14.42. Oxford Immunotec Global shares last traded at $14.46, with a volume of 93,865 shares.
OXFD has been the topic of several analyst reports. TheStreet upgraded Oxford Immunotec Global from a “d+” rating to a “c-” rating in a report on Tuesday, November 19th. Zacks Investment Research lowered Oxford Immunotec Global from a “buy” rating to a “hold” rating in a report on Wednesday, January 8th. Finally, BidaskClub lowered Oxford Immunotec Global from a “sell” rating to a “strong sell” rating in a report on Thursday, January 16th. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $19.67.
The company has a current ratio of 13.24, a quick ratio of 12.65 and a debt-to-equity ratio of 0.03. The firm has a fifty day moving average price of $16.04 and a 200 day moving average price of $15.47. The firm has a market cap of $384.80 million, a PE ratio of 2.81 and a beta of 0.42.
Oxford Immunotec Global Company Profile (NASDAQ:OXFD)
Oxford Immunotec Global PLC, a diagnostics company, focuses on developing and commercializing proprietary tests for immunology and infectious diseases in the United States. It develops its products using its T-SPOT technology platform, which enables the measurement of responses of specific immune cells to inform the diagnosis, prognosis, and monitoring of patients with immune-regulated conditions.
Read More: What are municipal bonds?
Receive News & Ratings for Oxford Immunotec Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Immunotec Global and related companies with MarketBeat.com's FREE daily email newsletter.